4.7 Article

Effect of denosumab on Japanese patients with rheumatoid arthritis: a dose-response study of AMG 162 (Denosumab) in patients with RheumatoId arthritis on methotrexate to Validate inhibitory effect on bone Erosion (DRIVE)-a 12-month, multicentre, randomised, double-blind, placebo-controlled, phase II clinical trial

Related references

Note: Only part of the references are listed.
Review Rheumatology

Treating rheumatoid arthritis to target: recommendations of an international task force

Josef S. Smolen et al.

ANNALS OF THE RHEUMATIC DISEASES (2010)

Article Medicine, General & Internal

Rheumatoid arthritis

David L. Scott et al.

LANCET (2010)

Article Medicine, General & Internal

Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis

Steven R. Cummings et al.

NEW ENGLAND JOURNAL OF MEDICINE (2009)

Article Medicine, General & Internal

Denosumab in postmenopausal women with low bone mineral density

MR McClung et al.

NEW ENGLAND JOURNAL OF MEDICINE (2006)

Review Rheumatology

Mechanisms of disease: the link between RANKL and arthritic bone disease

G Schett et al.

NATURE CLINICAL PRACTICE RHEUMATOLOGY (2005)

Article Rheumatology

Progression of radiologic damage in patients with rheumatoid arthritis in clinical remission

ETH Molenaar et al.

ARTHRITIS AND RHEUMATISM (2004)

Article Pathology

Osteoprotegerin ligand modulates murine osteoclast survival in vitro and in vivo

DL Lacey et al.

AMERICAN JOURNAL OF PATHOLOGY (2000)